InspireMD Inc (NSPR)
2.21
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
2.21
0.00 (0.00%)
After-Hours: 20:00
InspireMD Research and Development Expense (Quarterly): 2.035M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.035M |
| September 30, 2023 | 2.11M |
| June 30, 2023 | 1.993M |
| March 31, 2023 | 1.843M |
| December 31, 2022 | 2.013M |
| September 30, 2022 | 2.061M |
| June 30, 2022 | 2.056M |
| March 31, 2022 | 1.68M |
| December 31, 2021 | 1.534M |
| September 30, 2021 | 1.495M |
| June 30, 2021 | 1.29M |
| March 31, 2021 | 0.839M |
| December 31, 2020 | 0.72M |
| September 30, 2020 | 0.546M |
| June 30, 2020 | 0.444M |
| March 31, 2020 | 0.523M |
| December 31, 2019 | 0.522M |
| September 30, 2019 | 0.442M |
| June 30, 2019 | 0.865M |
| March 31, 2019 | 1.125M |
| December 31, 2018 | 0.637M |
| September 30, 2018 | 0.416M |
| June 30, 2018 | 0.23M |
| March 31, 2018 | 0.252M |
| December 31, 2017 | 0.235M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.288M |
| June 30, 2017 | 0.403M |
| March 31, 2017 | 0.35M |
| December 31, 2016 | 0.345M |
| September 30, 2016 | 0.289M |
| June 30, 2016 | 0.278M |
| March 31, 2016 | 0.379M |
| December 31, 2015 | 0.762M |
| September 30, 2015 | 0.781M |
| June 30, 2015 | 0.747M |
| March 31, 2015 | 1.352M |
| December 31, 2014 | 1.259M |
| September 30, 2014 | 2.46M |
| June 30, 2014 | 2.448M |
| March 31, 2014 | 2.577M |
| September 30, 2013 | 1.544M |
| June 30, 2013 | 1.047M |
| March 31, 2013 | 0.907M |
| December 31, 2012 | 1.256M |
| September 30, 2012 | 0.946M |
| March 31, 2012 | 1.349M |
| December 31, 2011 | 0.834M |
| September 30, 2011 | 0.547M |
| June 30, 2011 | 0.75M |
| March 31, 2011 | 0.343M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.442M
Minimum
Sep 2019
2.11M
Maximum
Sep 2023
1.316M
Average
1.495M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 6.08M |
| Retractable Technologies Inc | 0.1617M |
| Xtant Medical Holdings Inc | 0.492M |
| Asensus Surgical Inc | 8.614M |
| Catheter Precision Inc | -0.011M |